T3D
0.05
233.3%
PEN
0.33
-46.8%
GML
0.045
60.7%
RGL
0.003
-40%
ENT
0.008
60%
KLR
0.54
-34.1%
AIV
0.02
53.8%
JAV
0.002
-33.3%
QXR
0.006
50%
M2R
0.002
-33.3%
AQI
0.038
35.7%
RDS
0.004
-33.3%
NPM
0.018
28.6%
AOA
0.003
-25%
AHK
0.455
28.2%
BLZ
0.003
-25%
VML
0.165
26.9%
MEM
0.003
-25%
FIN
0.005
25%
LEG
0.007
-22.2%
VRC
0.005
25%
ADG
0.004
-20%
BCM
0.023
21.1%
CAV
0.004
-20%
FL1
0.12
20%
CVB
0.14
-20%
WHK
0.012
20%
FBR
0.004
-20%
S66
0.195
18.2%
IMI
0.008
-20%
KLS
4.76
18.1%
TRM
0.042
-19.2%
PAT
0.04
17.6%
GBE
0.06
-16.7%
NXL
2.41
17%
XGL
0.02
-16.7%
AJX
0.007
16.7%
ATV
0.016
-15.8%
AVE
0.007
16.7%
LU7
0.011
-15.4%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Vitrafy Life Sciences (ASX:VFY): Lists on ASX

Vitrafy Life Sciences has listed on the ASX with a ticker code of VFY. The company has designed and developed an innovative cryopreservation solution, which has application across many uses in animal and human health. Having proven its technology, Vitrafy is now pursuing additional product development initiatives and collaboration agreements.

Website: https://vitrafy.com/
Board: Sonia Petering – Chair, Assoc Professor John McBain – Chair, Scientific Advisory Board and Non-Executive Director, Brent Owens – Deputy Chief Executive Officer, Co-Founder and Executive Director, Kate Munnings – Chief Executive Officer, Vaughan Webber – Non‑Executive Director
Management: Kate Munnings – Chief Executive Officer, Simon Martin – Chief Financial Officer
Media: The Stock Network Lel Smits